Cannabis Law Report

JUNE 30, 2019

In this week’s edition: The US House passes bipartisan measure to prevent the Department of Justice from interfering with state medical and adult-use cannabis laws. The Delaware Senate passes legislation making violation of cannabis consumption/possession laws by minors a civil rather than criminal infraction.

Chronic Pain 40

Chronic Pain Legislation Treatment Programs 40

Cannabis Law Report

AUGUST 22, 2021

With decriminalization efforts underway in many other cities and states, this new training, the first of its kind in the US, could set the stage for the design and deployment of programs like it across the country. First responders in Denver, Colorado, will soon have another tool to support their community: psychedelic harm reduction.

Research and Development 105

Research and Development Decriminalization Education Safety 105

Cannabis Law Report

AUGUST 25, 2022

The bipartisan group of seven Commissioners, appointed by President Biden and confirmed by the Senate, allows the USSC to reach quorum and conduct its congressionally mandated activities for the first time since 2019. The MAPS Policy and Advocacy team coordinated a bipartisan coalition that met with U.S. Ismail L Ali, J.D.,

Research and Development 52

Research and Development Advocacy Clinical Trials Policy 52

NORML

JANUARY 2, 2019

NORML Chapters are Organized and Energized for State Legislative Sessions in 2019. California NORML Supports Legislation to Protect Cannabis Compassion Programs. These programs are now threatened by Prop. 64, which requires that all donations be taxed at the same rate as if they were sold.

Advocacy 125

Advocacy Decriminalization Legislation Cultivation 125

Cannabis Law Report

AUGUST 10, 2021

“At Khiron, sustainability is embedded in our DNA, with the common belief that strong ESG policies improve performance, loyalty, and innovation, while reducing corporate risks and capital costs. Khiron is a leading vertically integrated medical cannabis company with core operations in Latin America and Europe. 2020 ESG Highlights.

Supply Chain 98

Supply Chain Patients Consumption Events 98

Cannabis Law Report

SEPTEMBER 30, 2019

Part 2: To Lobby or Not to Lobby: That is the Cannabis Question. “ The cannabis business is booming in Florida. ” — Why lobby against cannabis? Cannabis lobbying groups are spending up to $60,000 a month apiece trying to win friends and persuade recalcitrant lawmakers to see their point of view.”

Banking 63

Banking Recreational Medicine Patients 63

Cannabis Law Report

JUNE 19, 2022

The new center is designed to formalize a network of experts across the university based in a range of academic departments as well as existing centers focused on drug policy and substance misuse prevention and recovery. Alan Davis. Jason Slot. The center’s initial $1.5

Education 52

Education Research and Development Therapy Clinical Trials 52

Cannabis Law Report

APRIL 8, 2022

MAPS continued to publish Bulletin articles about MDMA research , requests for donations , and discontinuing animal studies. MAPS hired Sylvia Thyssen as our first employee , celebrated the 50th anniversary of LSD , outlined perspectives on drug policy , and worked toward facilitating a pilot study for medical marijuana.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

NORML

JUNE 5, 2019

One of our main objectives for these seminars is to ensure patients have free resources and education around the new medical marijuana program. Donate today to support our efforts! Please support our efforts by making a one-time donation! Marijuana policy should be evidence based. Callicoat, M.D.

Education 37

Education Events Patients Programs 37

NORML

JULY 10, 2019

This is a big day: after patient years of steady gains one state at a time, we’re finally ready for serious marijuana policy reform at the federal level. That’s why, today, I am asking you to stand with me in the fight against the prohibition on pot and empower NORML with a donation. We worked hard. We worked together.

Policy 34

Policy History Programs Marijuana 34

Cannabis Law Report

JUNE 4, 2021

He has also donated significant sums of money to several different research centers and non-profits, and has influenced the funding of several large psychedelics initiatives. Amanda Feilding, Countess of Wemyss and March is an English drug policy reformer, lobbyist and research coordinator. in/timferriss/ [link]. Andrew Yang.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51